Buprenorphine Therapy for Opioid Use Disorder.
Buprenorphine Therapy for Opioid Use Disorder.
Am Fam Physician. 2018 Mar 01;97(5):313-320
Authors: Zoorob R, Kowalchuk A, Mejia de Grubb M
Abstract
Opioid misuse, including the use of heroin and the overprescribing, misuse, and diversion of opioid pain medications, has reached epidemic proportions in the United States. As a result, there has been a dramatic increase in opioid use disorder and associated overdoses and deaths. Addiction is a chronic brain disease with a genetic component that affects motivation, inhibition, and cognition. Patient characteristics associated with successful buprenorphine maintenance treatment include stable or controlled medical or psychiatric comorbidities and a safe, substance-free environment. As a partial opioid agonist, buprenorphine has a ceiling effect that limits respiratory depression and adds to its safety in accidental or intentional overdose. Buprenorphine and combinations of buprenorphine and naloxone are generally well tolerated; adverse effects include anxiety, constipation, dizziness, drowsiness, headache, nausea, and sedation. Family physicians who meet specific requirements can obtain a Drug Addiction Treatment Act of 2000 waiver by notifying the Substance Abuse and Mental Health Services Administration of their intent to begin dispensing and/or prescribing buprenorphine. Medication-assisted treatment with buprenorphine is as effective as methadone in terms of treatment retention and d...
Source: American Family Physician - Category: Primary Care Authors: Zoorob R, Kowalchuk A, Mejia de Grubb M Tags: Am Fam Physician Source Type: research
More News: Addiction | Anxiety | Brain | Chronic Pain | Constipation | Databases & Libraries | Depression | Environmental Health | Epidemics | Epidemiology | Genetics | Headache | Men | Methadone | Migraine | Neurology | Overdose | Pain | Psychiatry | Respiratory Medicine | Suboxone | Substance Abuse | Substance Abuse Disorders | USA Health